Thanks for the time taken to provide that info.
I see PRL developing in parallel and that is going gangbusters. By comparison, crickets.
I recall seeing a timeline for FIN at some point and I am sure feasibility was to be completed by now. And every time they put something out, parts of it get redacted. I assume clipped by the ASX. Something is not clicking.
While I hope it is not the case, my sense is that they think they are sitting on a decent prospect but do not have the capability (and certainly do not have the resources) to execute.
But there are others seeming moving quicker. And being first to critical in this space - particularly as not all of those with similar plans are going to get the required environmental approvals.
As I said earlier, if Mr Talbot can make it happen then he is worth every cent he will get.
- Forums
- ASX - By Stock
- Ann: Former Galaxy Resources Executive Appointed as Director
FIN
fin resources limited
Add to My Watchlist
0.00%
!
0.4¢

Thanks for the time taken to provide that info.I see PRL...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.432M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 800000 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 1130359 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 800000 | 0.003 |
5 | 2281928 | 0.002 |
5 | 8999037 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 1130359 | 4 |
0.005 | 840687 | 4 |
0.006 | 719305 | 5 |
0.007 | 998780 | 3 |
0.008 | 375124 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
FIN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online